Find Faculty
Home>Find Faculty>Christa Cooper, PA-C, MPH

Christa Cooper, PA-C, MPH

Department of Neurological Sciences, RUSH Medical College
Education

Doctor of Philosophy in Health Sciences, Rush University
Master of Medical Science/Physician Assistant Studies, Arcadia University
Master of Public Health, Arcadia University

Contact Info:

1725 W. Harrison St.

Suite 755

Chicago, IL 60612

Phone: (312) 563-2900
Links:
Honors and Activities
  • Nominated for Outstanding PA of the Year
  • American Academy of Neurology Advanced Practice Provider Award
  • Huntington Study Group CME4HD Scholarship
  • Inducted into the Pi Alpha National Honor Society for Physician Assistants
Grants
Research
  • The Value of Physician Assistants in a Movement Disorder Clinic, Jan 2023-present: Principal Investigator
  • Development of the Virtual Unified Huntington’s Disease Rating Scale, Dec 2023-present: Principal Investigator
  • Evaluation of the Safety and Effectiveness of Exablate Ablation of the Pallidothalamic Tract for the Treatment of Bilateral Motor Complications of Parkinson’s Disease, April 2022-present: Co-Investigator
  • Abbott DBS Registry of Outcomes for Indications over Time, Feb 2022-present: Co-Investigator
  •  Outcomes Analysis of Awake vs Asleep DBS Surgery,Jan 2022-present - Co-investigator
  • Advance Directive Documentation in a Huntington’s Disease Clinic, March 2021-Nov 2021 - Principal Investigator
  • Reliability and Stability of Programming Directional Deep Brain Stimulation, Jan 2021-June 2021 - Co-Investigator
  • Psychometric Validation Study for the Huntington’s Disease Everyday Functioning (Hi-DEF) Scale, Sept 2021-Jan 2022 - Co-Investigator
  • Registry of Deep Brain Stimulation with the VERCISE System, May 2021-present - Co-Investigator
  • KINECT HD2: Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated with Huntington Disease, Sept 2020-present - Co-Investigator
  • A Phase I/II, Randomized, Double-blind, Sham Control Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Ascending Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT-130) in Early Manifest Huntington Disease, Aug 2020-present - Co-investigator
  • Optimization of Telegenetic Counseling for Huntington’s Disease, June 2021-Dec 2022 - Co-Investigator
  • KINECT HD: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease, Feb 2020-April 2022 - Co-investigator
  • Enroll HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort. A CHDI Foundation Project, July 2017-present - Co investigator
  • Psychosis in Parkinson’s disease symptom identification tool, July 2017-June 2018 - Co-Investigator
Grants
  • American Academy of Physician Assistants Research Grant: The Value of Physician Assistants in a Movement Disorder Clinic